Devin T. Wiley, Ph.D.
Affiliations: | 2013 | Chemical Engineering | California Institute of Technology, Pasadena, CA |
Area:
Catalysis, Molecular TherapyGoogle:
"Devin Wiley"Mean distance: 10.6
Parents
Sign in to add mentor| Mark E. Davis | grad student | 2013 | Caltech | |
| (Design of Nanoparticles That Cross the Blood-Brain Barrier by Receptor Mediated Transcytosis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chao J, Lin J, Frankel P, et al. (2017) Pilot trial of CRLX101 in patients with advanced, chemotherapy-refractory gastroesophageal cancer. Journal of Gastrointestinal Oncology. 8: 962-969 |
| Clark AJ, Wiley DT, Zuckerman JE, et al. (2016) CRLX101 nanoparticles localize in human tumors and not in adjacent, nonneoplastic tissue after intravenous dosing. Proceedings of the National Academy of Sciences of the United States of America |
| Chao J, Lin J, Frankel PH, et al. (2016) Pilot trial of CRLX101 in patients (pts) with advanced, chemotherapy-refractory gastroesophageal cancer (GEC). Journal of Clinical Oncology. 34: 44-44 |
| Clark A, Wiley DT, Zuckerman JE, et al. (2015) Abstract B33: CRLX101, an investigational nanoparticle-drug conjugate, localizes in human tumors and not in adjacent healthy tissue after intravenous dosing Molecular Cancer Therapeutics. 14 |
| Eliasof S, Lazarus D, Peters CG, et al. (2013) Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticle. Proceedings of the National Academy of Sciences of the United States of America. 110: 15127-32 |
| Wiley DT, Webster P, Gale A, et al. (2013) Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor. Proceedings of the National Academy of Sciences of the United States of America. 110: 8662-7 |